Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report)’s stock price hit a new 52-week low on Tuesday . The stock traded as low as $22.30 and last traded at $22.43, with a volume of 50356 shares trading hands. The stock had previously closed at $22.49.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the stock. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the stock from $38.00 to $27.00 in a report on Monday. JMP Securities lifted their price target on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their target price for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $30.83.
Get Our Latest Stock Analysis on OPCH
Option Care Health Stock Performance
Insider Transactions at Option Care Health
In related news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.
Institutional Investors Weigh In On Option Care Health
Several institutional investors and hedge funds have recently bought and sold shares of OPCH. UMB Bank n.a. increased its stake in shares of Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC raised its position in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its stake in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after acquiring an additional 1,446 shares during the period. Blue Trust Inc. raised its holdings in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares in the last quarter. Finally, SageView Advisory Group LLC acquired a new stake in Option Care Health in the first quarter worth approximately $85,000. Institutional investors and hedge funds own 98.05% of the company’s stock.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
- Five stocks we like better than Option Care Health
- Using the MarketBeat Dividend Yield Calculator
- 2 Online Educational Platforms Staging a Turnaround
- What to Know About Investing in Penny Stocks
- Top 3 Sectors Outperforming After Trump’s Victory
- The How And Why of Investing in Oil Stocks
- Sono-Tek’s $2M Buyback: A Buying Opportunity in Clean Tech
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.